On Tuesday, Transmedics Group Inc (NASDAQ: TMDX) opened lower -5.16% from the last session, before settling in for the closing price of $168.06. Price fluctuations for TMDX have ranged from $36.42 to $177.37 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Over the past five-year period, the growth rate of yearbook sales for the company of the Healthcare sector was 95.07%. Company’s average yearly earnings per share was noted 264.15% at the time writing. With a float of $32.21 million, this company’s outstanding shares have now reached $32.67 million.
Considering the fact that the conglomerate employs 584 people, you should pay attention to its efficiency factor. In terms of profitability, gross margin is 60.66%, operating margin of -0.22%, and the pretax margin is 0.41%.
Transmedics Group Inc (TMDX) Insider Activity
A key investor’s attitude towards the stock of the Medical Devices industry is another important factor to consider. The insider ownership of Transmedics Group Inc is 3.44%, while institutional ownership is 102.64%. The most recent insider transaction that took place on Aug 27 ’24, was worth 1,760,200. In this transaction an insider of this company sold 10,000 shares at a rate of $176.02, taking the stock ownership to the 21,105 shares. Before that another transaction happened on Aug 27 ’24, when Company’s Officer proposed sale 10,000 for $176.02, making the entire transaction worth $1,760,158.
Transmedics Group Inc (TMDX) Earnings and Forecasts
According to the Wall Street analysts, stocks earnings will be around 264.15% per share during the next fiscal year.
Transmedics Group Inc (NASDAQ: TMDX) Trading Performance Indicators
Check out the current performance indicators for Transmedics Group Inc (TMDX). In the past quarter, the stock posted a quick ratio of 8.48. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 14.82.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 0.04, a number that is poised to hit 0.29 in the next quarter and is forecasted to reach 1.85 in one year’s time.
Technical Analysis of Transmedics Group Inc (TMDX)
Compared to the last year’s volume of 0.76 million, its volume of 0.57 million showed lagged in the last five days. As of the previous 9 days, the stock’s Stochastic %D was 29.41%. Additionally, its Average True Range was 8.10.
During the past 100 days, Transmedics Group Inc’s (TMDX) raw stochastic average was set at 80.96%, which indicates a significant increase from 14.29% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 44.21% in the past 14 days, which was lower than the 58.21% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $154.38, while its 200-day Moving Average is $109.37. Nevertheless, the first resistance level for the watch stands at $165.32 in the near term. At $171.26, the stock is likely to face the second major resistance level. The third major resistance level sits at $175.73. If the price goes on to break the first support level at $154.91, it is likely to go to the next support level at $150.44. Should the price break the second support level, the third support level stands at $144.50.
Transmedics Group Inc (NASDAQ: TMDX) Key Stats
There are currently 32,937K shares outstanding in the company with a market cap of 5.32 billion. Presently, the company’s annual sales total 241,620 K according to its annual income of -25,030 K. Last quarter, the company’s sales amounted to 114,310 K and its income totaled 12,190 K.
